Marco J. Schnabel

Erdafitinib versus pembrolizumab in pretreated patients with advanced or metastatic urothelial cancer with select FGFR alterations: cohort 2 of the randomized phase III THOR trial

Arlene O. Siefker‐Radtke, Nobuaki Matsubara, S.H. Park et al. · Annals of Oncology · 2023 · 80 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Incidence and risk factors of renal hematoma: a prospective study of 1,300 SWL treatments

Marco J. Schnabel, Michael Gierth, C. Chaussy et al. · Urolithiasis · 2014 · 32 citations

Medicine, Nephrology, Hemodialysis +4

Prediction of cancer‐specific survival after radical cystectomy in <scp>pT4a</scp> urothelial carcinoma of the bladder: development of a tool for clinical decision‐making

Atiqullah Aziz, Shahrokh F. Shariat, Florian Roghmann et al. · British Journal of Urology · 2014 · 31 citations

Medicine, Oncology, Urology +16

Critical evaluation of molecular tumour board outcomes following 2 years of clinical practice in a Comprehensive Cancer Centre

Alexander Scheiter, Frederik Hierl, Florian Lüke et al. · British Journal of Cancer · 2022 · 30 citations · Full text

Medicine, Oncology, Pathology +13

Oncological Outcome and Value of Postoperative Magnetic Resonance Imaging after Focal High-Intensity Focused Ultrasound Therapy for Prostate Cancer

Bernd Rosenhammer, Laura Rotzinger, Marco J. Schnabel et al. · Urologia Internationalis · 2019 · 23 citations

Medicine, Oncology, Surgery +17